A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1
Clinical trial NCT03679455 · UNKNOWN
Trial details
- NCT number
- NCT03679455
- Sponsor
- Polish Myeloma Consortium
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2019-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.